About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:2175761
Allelic
Composition
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Genetic
Background
involves: 129S4/SvJaeSor * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cdkn1btm1Mlf mutation (2 available); any Cdkn1b mutation (25 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• Background Sensitivity: no indication of early mortality at 9 months of age on the mixed 129/Sv and C57BL/6J background, however on a 129/Sv background, majority die with massively enlarged pituitary tumors

growth/size/body
• body weight increase becomes evident between 2-3 weeks of age, is maximal by 10 weeks of age, and is maintained throughout adulthood and is partly attributable to enlargement of all internal organs, however do not have an increase in body fat amount
• disproportionately enlarged
• becomes evident by 4 weeks of age

neoplasm
• adenomatous, neoplastic transformation of the pars intermedia

endocrine/exocrine glands
• disproportionately enlarged
• gross hyperplasia becomes evident at 8-10 weeks of age
• disproportionately enlarged
• becomes evident by 4 weeks of age
• 3-fold increase in the number of thymocytes, however development of thymocytes is normal
• secondary ovarian follicles develop but do not progress to form corpora lutea
• adenomatous, neoplastic transformation of the pars intermedia

immune system
• thymoblasts and splenic T cells have an increase in percentage of S phase cells and a 3-4-fold increase in cyclin E-associated kinase activity, indicating increased cell proliferation
• disproportionately enlarged
• becomes evident by 4 weeks of age
• 3-fold increase in the number of thymocytes, however development of thymocytes is normal
• disproportionately enlarged
• becomes evident by 4 weeks of age

hematopoietic system
• thymoblasts and splenic T cells have an increase in percentage of S phase cells and a 3-4-fold increase in cyclin E-associated kinase activity, indicating increased cell proliferation
• disproportionately enlarged
• becomes evident by 4 weeks of age
• 3-fold increase in the number of thymocytes, however development of thymocytes is normal
• increase in the number of granulocyte-macrophage, early and late erythroid progenitors, and megakaryotic progenitors in both the marrow and spleen
• disproportionately enlarged
• becomes evident by 4 weeks of age

liver/biliary system
• average of 23% increase in hepatocyte cell density

reproductive system
• secondary ovarian follicles develop but do not progress to form corpora lutea
• females do not become pregnant, however, exogenous administration of gonadotropins induced ovulation, differentiation of the corpora lutea, and early development of viable embryos, with embryos implanting but not developing to term

vision/eye
• loss of the normally sharp boundary between the inner and outer nuclear layer
• subtle disorganization of the retina

nervous system
• disproportionately enlarged
• gross hyperplasia becomes evident at 8-10 weeks of age
• adenomatous, neoplastic transformation of the pars intermedia
• about 30% increase in neuronal cell density in the habenular nucleus
• about 30% increase in neuronal cell density in the hippocampus
• about 30% increase in neuronal cell density in the cerebral cortex

cellular
• thymoblasts and splenic T cells have an increase in percentage of S phase cells and a 3-4-fold increase in cyclin E-associated kinase activity, indicating increased cell proliferation


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory